Past Regional Co-Chairs

In order to facilitate and incorporate local participation, local co-chairs are recruited each year. In previous years, Local Co-Chairs were:

Chicago, IL, 2006

  • Panayiotis P. Constantinides, PhD, Principal, Biopharmaceutical & Drug Delivery Consulting
  • Elsie Quaite-Randall, PhD, MBA Executive Director of the Office of Research Contracts and IP, McMaster University, formerly of Office of Technology Transfer, Argonne National Laboratory

Boston, MA, 2007

  • Robert Creeden, Partners HealthCare Systems, Inc., Managing Director, Center for Innovative Ventures

San Diego, CA, 2008

  • Kurt A. May, MBA, Assistant Dean, Executive Development Center, Rady School of Management, University of California, San Diego
  • Duane J. Roth, Chief Executive Officer and Member of the Board of CONNECT.

Atlanta, GA, 2009

  • Frank R. Hunt, MS MBA, President, SE bioStrategies, Inc., CEO, PNP Therapeutics, Inc.
  • Dennis P. Schafer, CEO, Life Science Management

Chicago, IL, 2010

  • Patrick G. Morand, Managing Director, SWMF Life Science Fund
  • Charles B. Hoslet, Managing Director, UW-Madison Office of Corporate Relations
  • Allen J. Dines, Assistant Director, Office of Corporate Relations, University of Wisconsin

Washington, DC, 2011

  • Elana Fine, Director of Venture Investments, Dingman Center for Entrepreneurship, Robert H. Smith School of Business, University of Maryland
  • Toby Gordon, Sc.D., Associate Professor, The Johns Hopkins Carey Business School
  • Martha J. Connolly, PhD, Director, Maryland Industrial Partnerships, University of Maryland

Boston, MA, 2012

  • Ashley J. Stevens, DPhil (Oxon), CLP, President, Focus IP Group, LLC and Lecturer, Strategy and Innovation Department, School of Management, Boston University
  • Rekha Paleyanda, PhD, Sr. Business Strategy and Licensing Manager, Partners Healthcare

Chicago, IL, 2013

  • Patrick G. Morand, Managing Partner, Open Prairie Ventures
  • Allen J. Dines, Assistant Director, Office of Corporate Relations & Venture Designer Hybrid Zone X, University of Wisconsin-Madison

San Diego, CA, 2014

  • Kurt A. May, MBA, Co-founder and Chairman, Psynomics Incorporated
  • Larry Stambaugh, Founding Principal, Aperçu Partners
  • Justin Chakma, Associate Director, Auspex Pharmaceuticals and Thomas, McNerney & Partners, LLC

Philadelphia, PA, 2015

  • Dennis Gross, MS, PhD, CEO, Pennsylvania Drug Discovery Institute at The Pennsylvania Biotechnology Center
  • James Jordan, MBA, CHT, Chief Investment Officer, Pittsburgh Life Sciences Greenhouse, Distinguished Service Professor in Healthcare & Biotechnology Management, Carnegie Mellon University
  • Alex B. Reitz, PhD, CEO, Fox Chase Chemical Diversity Center, Inc., The Pennsylvania Biotechnology Center

San Francisco, CA 2016

  • Benjamin Chen, PhD, Managing Director, Ignatius Transaction Partners
  • Moira Gunn, PhD, Host, NPR – BioTech Nation, Director, Business of Biotechnology Program, Professor, School of Management University of San Francisco

San Diego, CA 2017

  • Steve Flaim, PhD, FACC, FAHA, Chairman Emeritus, Tech Coast Angels, Director Angel Capital Association  
  • Larry Stambaugh, Founding Principal, Aperçu Partners, Numerous Boards of Directors

Boston, MA 2018

  • Edward Ross, Jr., MBA, President & CEO, ReadyDock, Inc., Member, MassMedical Angels and Launchpad Venture Group
  • Amy Siegel, MA, Co-founder and President, S2N Health

Philadelphia, PA 2019

  • Wendy DiCicco, Board Member, Carmell Therapeutics
  • Kathryn Doyle, PhD, JD, Partner, Saul Ewing Arnstein & Lehr, LLP
  • Hank Safferstein, PhD, JD, MBA, Senior Vice President, Cognition Therapeutics